Prostate Cancer Market Analysis Worldwide 2019 -Global Trends, Size, Analysis, Emerging Factors, Competitive Landscape, Regional Analysis and Forecast to 2025

Market Research Future (MRFR) has launched a new release on the Prostate Cancer Market Research Report – Global Forecast till 2025. The report delivers a thorough understanding of the market’s present status and likely future growth trajectory over the forecast period.

The global prostate cancer market was valued at USD 10 billion in 2018 and is expected to exhibit a strong 7.1% CAGR over the forecast period between 2018 and 2025, according to the latest research report from Market Research Future (MRFR). The global prostate cancer market is expected to be driven mostly by the growing awareness about prostate cancer and the increasing entry of effective prostate cancer medication, according to MRFR.

Segmentation:

The global prostate cancer market is segmented on the basis of treatment, end user, and region.

By treatment, the global prostate cancer market is segmented into surgery and medication. The medication segment is further sub-segmented into chemotherapy, targeted therapy, immunotherapy, hormone therapy, monoclonal antibodies, and others.

By end use, the global prostate cancer market is segmented into hospitals and specialty centers.

Regional Analysis:

The Americas is the largest regional market for prostate cancer, followed by Europe. The widespread awareness about prostate cancer in North America has been a vital driver for the global prostate cancer market. According to the American Cancer Society, prostate cancer is the most common type of cancer among American men, and over 160,000 new cases were registered in 2018. The high geriatric population in North America and Europe is also a major driver for the global prostate cancer market.

Prostate Cancer Market – Competitive Landscape

Highly competitive, the prostate cancer market appears to be fragmented due to the presence of several notable players. To gain a substantially large competitive advantage, these players incorporate strategic initiatives such as mergers & acquisitions, collaboration, expansion, and product launch. Due to the increasing strategic partnerships, the structure of the market is changing rapidly. Besides, the growing competition in the market is encouraging multinational companies to acquire small yet promising companies operating in the developing markets.

Get Global Prostate Cancer Research Report: Information by Treatment [Medication (Chemotherapy, Monoclonal Antibodies, Targeted Therapy, Immunotherapy and Hormone Therapy) and Surgery], End User (Hospitals & Clinics, Ambulatory Surgical Centres, Specialty Centres, Others) and Region (the Americas, Europe, Asia-Pacific and the Middle East & Africa) - Forecast till 2025

@ https://www.marketresearchfuture.com/reports/prostate-cancer-market-1580

Major Players

Players leading the global prostate cancer market include Bayer Pharma AG (Berlin), OncoGenex Pharmaceuticals Inc. (US), Progenics Pharmaceuticals, Inc. (US), OncBioMune Pharmaceuticals Inc. (US), TOLMAR Inc. (US), Endo Pharmaceuticals Inc., and Tokai Pharmaceuticals, Inc., among others.

Latest Trending Reports

Global Needle-Free Diabetes Care Market Research Report- Forecast To 2027

Global High Throughput Screening Market Research Report- Forecast To 2027

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com